Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Reparixin in Pancreatic Islet Transplantation for Type 1 Diabetes
2011-006201-10Phase 3Completed
- Sponsor
- Dompé
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) and Pancreatic islet transplantation recipient comparing Reparixin with Placebo (2 arms). Primary endpoint: MMTT C-peptide AUC normalized by islet equivalent per kg. Started May 2012; status: completed.
02
Drugs
reparixin
03
Conditions
diabetes mellitus type 1 (T1D)Pancreatic islet transplantation recipient
Beyond the preview
Go deeper on 2011-006201-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006201-10.